Meningioma pathology, genetics, and biology.
Over the past 5 to 10 years, important advances were made in the understanding of meningioma biology. Progress in molecular genetics probably represents the most important accomplishment in the comprehensive knowledge of meningioma pathogenesis. Several genes could be identified as targets for mutation or inactivation. Additional chromosomal regions were found to be commonly deleted or amplified, suggesting the presence of further tumor suppressor genes or proto-oncogenes, respectively, in these regions. Histopathologically, the most important innovation is represented by the revised WHO classification in the year 2000. Meningioma grading criteria in the new classification scheme are more precise and objective, and should thus improve consistency in predicting tumor recurrence and aggressive behavior. This review focuses mainly on the advances in molecular biology that were achieved in recent years. It summarizes the most important aspects of meningioma classification as the basis to place biological observations into a correlative context, and, further, includes mechanisms of angiogenesis and edema formation as well as the role of hormone receptors in meningiomas.
Lamszus
Katrin
K
Department of Neurosurgery, University Hospital Hamburg-Eppendorf, Hamburg, Germany. lamszus@uke.uni-hamburg.de
D000818:Animals; D005260:Female; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000145:classification* / Q000235:genetics* / Q000473:pathology*; D008579:Meningioma / Q000145:classification* / Q000235:genetics* / Q000473:pathology*; D009154:Mutation; D009389:Neovascularization, Pathologic; D011379:Prognosis